| Name
|
Arg-Gly-Asp-Cys
|
| Other Name
|
RGDC
|
| Sequence (Single letter abbreviations)
|
RGDC
|
| Sequence（Three letter abbreviations）
|
{ARG}{GLY}{ASP}{CYS}
|
| Basic description
|
Films formed from 1,12-diphosphonododecane were treated with zirconium tetra (tert-butoxide) to give surface Zr complex species; derivatives of these surface complexes are stable to hydrolysis under physiological conditions and are mechanically strong. The cell attractive peptide derivative ARG-GLY-ASP-CYS, RGDC can be bound to these surface Zr alkoxide complexes through (maleimido) alkylcarboxylate intermediates. Surfaces modified with RGDC were shown to be effective for osteoblast binding and proliferation.
|
| Solubility
|
Soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weight out a smaller portion of the contents.
|
| The molecular weight
|
449.480
|
| Chemical formula
|
C15H27N7O7S1
|
| The purity
|
> 95%
|
| Storage conditions
|
Before using, store the peptide in the DRY form at 0-5°C. For and repeatable results, rehydrate the peptide immediately before using. Do not re-freeze any unused portions.
|
| Annotation
|
Inhibits platelet aggregation and fibrinogen binding
|
| Documents
|
|
| Figures
|
|
| Reference
|
|
Arg-Gly-Asp-Cys
